Review paper
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
Abstract
Low-density lipoprotein cholesterol (LDL-C) is a modifiable risk factor for the development of atherosclerotic cardiovascular disease. Statins have been the gold standard for managing cholesterol levels and reducing the risks associated with atherosclerotic cardiovascular disease; however, many patients do not achieve their cholesterol goals or are unable to tolerate this drug class due to adverse drug events. Recent studies of non-statin...
Paper Details
Title
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
Published Date
Nov 17, 2021
Volume
8